GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Bellevue Life Sciences Acquisition Corp (NAS:BLAC) » Definitions » Price-to-Tangible-Book

Bellevue Life Sciences Acquisition (Bellevue Life Sciences Acquisition) Price-to-Tangible-Book : 1.86 (As of May. 16, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bellevue Life Sciences Acquisition Price-to-Tangible-Book?

As of today (2024-05-16), Bellevue Life Sciences Acquisition's share price is $10.76. Bellevue Life Sciences Acquisition's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $5.78. Hence, Bellevue Life Sciences Acquisition's Price to Tangible Book Ratio of today is 1.86.

The historical rank and industry rank for Bellevue Life Sciences Acquisition's Price-to-Tangible-Book or its related term are showing as below:

BLAC' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.82   Med: 1.82   Max: 1.86
Current: 1.86

During the past 4 years, Bellevue Life Sciences Acquisition's highest Price to Tangible Book Ratio was 1.86. The lowest was 1.82. And the median was 1.82.

BLAC's Price-to-Tangible-Book is ranked worse than
50.9% of 499 companies
in the Diversified Financial Services industry
Industry Median: 1.8 vs BLAC: 1.86

A closely related ratio is called PB Ratio. As of today, Bellevue Life Sciences Acquisition's share price is $10.76. Bellevue Life Sciences Acquisition's Book Value per Sharefor the quarter that ended in Dec. 2023 was $5.78. Hence, Bellevue Life Sciences Acquisition's P/B Ratio of today is 1.86.


Bellevue Life Sciences Acquisition Price-to-Tangible-Book Historical Data

The historical data trend for Bellevue Life Sciences Acquisition's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bellevue Life Sciences Acquisition Price-to-Tangible-Book Chart

Bellevue Life Sciences Acquisition Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
- - - 1.82

Bellevue Life Sciences Acquisition Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 1.33 1.35 1.37 1.82

Competitive Comparison of Bellevue Life Sciences Acquisition's Price-to-Tangible-Book

For the Shell Companies subindustry, Bellevue Life Sciences Acquisition's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bellevue Life Sciences Acquisition's Price-to-Tangible-Book Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Bellevue Life Sciences Acquisition's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Bellevue Life Sciences Acquisition's Price-to-Tangible-Book falls into.



Bellevue Life Sciences Acquisition Price-to-Tangible-Book Calculation

Bellevue Life Sciences Acquisition's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=10.76/5.783
=1.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Bellevue Life Sciences Acquisition Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Bellevue Life Sciences Acquisition's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Bellevue Life Sciences Acquisition (Bellevue Life Sciences Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
10900 NE 4th Street, Suite 2300, Bellevue, WA, USA, 98004
Website
Bellevue Life Sciences Acquisition Corp is a blank check company.
Executives
David Jin Yoo officer: Chief Financial Officer (135-270) 7TH FLOOR, SOFTFORUM B/D., 545-7 DOGOKDONG, GANGNAM, SEOUL M5 135-170
Kuk Hyoun Hwang director, 10 percent owner, officer: Chief Executive Officer 10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Bellevue Global Life Science Investors Llc 10 percent owner 10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Steven Reed other: Director Nominee 2843-122 PL. N.E., BELLEVUE WA 98005
In Chul Chung other: Director Nominee 10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Hosun Euh other: Director Nominee 10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Jin Whan Park other: Director Nominee 10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Jun Chul Whang director 10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Rad Roberts other: Director Nominee 10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004